The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

European Journal of Surgical Oncology

Volumn 31, Issue 2, 2005, Pages 164-169

  Ni, Xiao Guang ^a   Bai, X F ^a   Mao, Y L ^b   Shao, Y F ^a   Wu, J X ^a   Shan, Y ^a   Wang, C F ^a   Wang, J ^a   Tian, Y T ^a   Liu, Q ^a   Xu, D K ^a   Zhao, P ^a  

^a CANCER HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

CA19 9; CA242; CEA; Pancreatic cancer; Tumour markers

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILIRUBIN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, ISLET CELL; CHOLANGIOCARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 13444312214     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.09.007     Document Type: Article

References (13)

1. N. Sawabu H. Watanabe Y. Yamaguchi K. Ohtsubo Y. Motoo Serum tumor markers and molecular biological diagnosis in pancreatic cancer Pancreas 28 2004 263-267
2. X.Y. Zhao S.Y. Yu S.P. Da L. Dai X.Z. Guo X.J. Dai Y.M. Wang A clinical evaluation of serological diagnosis for pancreatic cancer World J Gastroenterol 4 1998 147-149
3. International Union Against Cancer (UICC) In: L.H. Sobin C.H. Wittekind TNM classification of malignant tumors 5th ed 1997 Wiley New York
4. F. Gansauge S. Gansauge N. Parker M.I. Beger B. Poch K.H. Link F. Safi H.G. Beger CAM 17.1 - a new diagnostic marker in pancreatic cancer Br J Cancer 74 1996 1997-2002
5. C. Balague G. Gambus C. Carrato N. Porchet J.P. Aubert Y.S. Kim F.X. Real Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines Gastroenterology 106 1994 1054-1061
6. D.C. Chhieng E. Benson I. Eltoum M.A. Eloubeidi N. Jhala D. Jhala G.P. Siegal W.E. Grizzle U. Manne MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration Cancer 99 2003 365-371
7. H. Yamasaki S. Ikeda M. Okajima Y. Miura T. Asahara N. Kohno F. Shimamoto Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors Int J Oncol 24 2004 107-113
8. C. Haglund Tumour marker antigen CA125 in pancreatic cancer: A comparison with CA19-9 and CEA Br J Cancer 54 1986 897-901
9. M. Carpelan-Holmstrom J. Louhimo U.H. Stenman H. Alfthan C. Haglund CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers Anticancer Res 22 2002 2311-2316
10. S. Benchimol A. Fuks S. Jothy N. Beauchemin K. Shirota C.P. Stanners Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule Cell 57 1989 327-334
11. E.L. Berg M.K. Robinson O. Mansson E.C. Butcher J.L. Magnani A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1 J Biol Chem 266 1991 14869-14872
12. I.R. Lai W.J. Lee M.T. Huang H.H. Lin Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterology 49 2002 1157-1160
13. J. Lundin P.J. Roberts P. Kuusela C. Haglund Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9 Anticancer Res 15 1995 2181-2186